دورية أكاديمية
أعرض في EDS

New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma.

التفاصيل البيبلوغرافية
العنوان: New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma.
المؤلفون: Chang X; The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, China., Ma Z; The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, China., Zhu G; The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, China., Lu Y; The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, China., Yang J; The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu 730000, China.
المصدر: Journal of bone oncology [J Bone Oncol] 2021 Jun 23; Vol. 29, pp. 100372. Date of Electronic Publication: 2021 Jun 23 (Print Publication: 2021).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101610292 Publication Model: eCollection Cited Medium: Print ISSN: 2212-1366 (Print) Linking ISSN: 22121366 NLM ISO Abbreviation: J Bone Oncol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Amsterdam : Elsevier, c2012-
مستخلص: Mesenchymal stem cells (MSCs) are multipotent stem cells with significant potential for regenerative medicine. The tumorigenesis of osteosarcoma is an intricate system and MSCs act as an indispensable part of this, interacting with the tumor microenvironment (TME) during the process. MSCs link to cells by acting on each component in the TME via autocrine or paracrine extracellular vesicles for cellular communication. Because of their unique characteristics, MSCs can be modified and processed into good biological carriers, loaded with drugs, and transfected with anticancer genes for the targeted treatment of osteosarcoma. Previous high-quality reviews have described the biological characteristics of MSCs; this review will discuss the effects of MSCs on the components of the TME and cellular communication and the prospects for clinical applications of MSCs.
(© 2021 The Authors. Published by Elsevier GmbH.)
References: Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4822-7. (PMID: 19264968)
Oncogene. 2013 Oct 10;32(41):4970-80. (PMID: 23222711)
J Vis Exp. 2018 May 6;(135):. (PMID: 29782011)
Carcinogenesis. 2009 Oct;30(10):1789-95. (PMID: 19635748)
J Cell Physiol. 2020 May;235(5):4734-4745. (PMID: 31637737)
Cancer Res. 2007 Aug 1;67(15):7308-18. (PMID: 17671200)
J Gene Med. 2015 Mar-May;17(3-5):87-99. (PMID: 25808408)
Cancer Lett. 2020 Oct 10;490:54-65. (PMID: 32682951)
Nanomedicine (Lond). 2016 Sep;11(18):2431-41. (PMID: 27558906)
Cell Death Dis. 2018 Jun 18;9(7):714. (PMID: 29915309)
Blood. 2005 Jul 15;106(2):756-63. (PMID: 15817682)
J Gene Med. 2015 Jan-Feb;17(1-2):54-67. (PMID: 25677845)
J Control Release. 2015 Dec 10;219:278-294. (PMID: 26143224)
Int J Mol Sci. 2018 Oct 04;19(10):. (PMID: 30287763)
J Clin Invest. 2010 Feb;120(2):457-71. (PMID: 20093776)
Curr Stem Cell Res Ther. 2019;14(1):43-51. (PMID: 30112998)
Blood. 2006 Dec 1;108(12):3938-44. (PMID: 16896152)
Cancer Gene Ther. 2007 Nov;14(11):894-903. (PMID: 17693990)
Cell Mol Life Sci. 2014 Apr;71(8):1353-74. (PMID: 24158496)
Clin Transl Med. 2014 May 09;3:10. (PMID: 24949190)
J Hematol Oncol. 2014 Feb 06;7:14. (PMID: 24502410)
Nat Rev Drug Discov. 2017 Mar;16(3):203-222. (PMID: 28209991)
Genes Dev. 2008 Jun 15;22(12):1662-76. (PMID: 18559481)
Nat Med. 2013 Nov;19(11):1423-37. (PMID: 24202395)
Cell Commun Signal. 2018 Apr 6;16(1):13. (PMID: 29625612)
Stem Cells Transl Med. 2019 Sep;8(9):880-886. (PMID: 31045328)
Trends Cell Biol. 2015 Apr;25(4):198-213. (PMID: 25540894)
Cancer Immunol Immunother. 2020 Sep;69(9):1841-1854. (PMID: 32350594)
J Bone Oncol. 2020 Feb 04;21:100280. (PMID: 32082984)
PLoS One. 2011;6(12):e28321. (PMID: 22205945)
Stem Cells. 2017 Jun;35(6):1446-1460. (PMID: 28316123)
Cytokine. 2002 Mar 7;17(5):234-42. (PMID: 12027404)
Biol Blood Marrow Transplant. 2005 May;11(5):321-34. (PMID: 15846285)
Cancer Lett. 2017 May 1;393:94-102. (PMID: 28202351)
Clin Orthop Surg. 2016 Mar;8(1):1-8. (PMID: 26929793)
Int J Cancer. 2017 Mar 15;140(6):1331-1345. (PMID: 27888521)
World J Stem Cells. 2016 Mar 26;8(3):73-87. (PMID: 27022438)
PLoS One. 2016 Nov 3;11(11):e0166027. (PMID: 27812189)
Annu Rev Pathol. 2016 May 23;11:421-49. (PMID: 27193454)
Clin Cancer Res. 2016 Aug 15;22(16):4005-13. (PMID: 27370607)
Nat Commun. 2019 May 20;10(1):2226. (PMID: 31110221)
Br J Pharmacol. 2018 Jul;175(14):3034-3049. (PMID: 29722898)
Cancer Gene Ther. 2020 Dec;27(12):854-868. (PMID: 32418986)
Mol Oncol. 2018 May;12(5):659-676. (PMID: 29517849)
Stem Cells Transl Med. 2018 Sep;7(9):651-663. (PMID: 30070053)
J Biochem. 2020 Sep 1;168(3):265-271. (PMID: 32302384)
Front Cell Dev Biol. 2020 May 25;8:353. (PMID: 32523950)
Theranostics. 2019 Apr 12;9(8):2325-2345. (PMID: 31149047)
Curr Opin Struct Biol. 2019 Jun;56:131-138. (PMID: 30822656)
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11851-6. (PMID: 18697945)
World J Surg Oncol. 2015 Feb 15;13:52. (PMID: 25890096)
Int J Oncol. 2008 Dec;33(6):1231-8. (PMID: 19020756)
Drug Des Devel Ther. 2015 Feb 17;9:969-76. (PMID: 25733814)
Int J Clin Exp Pathol. 2017 Aug 01;10(8):8479-8486. (PMID: 31966700)
Nanomedicine. 2018 Oct;14(7):1973-1985. (PMID: 29935333)
Int J Mol Sci. 2016 Jul 11;17(7):. (PMID: 27409610)
Stem Cells. 2009 Oct;27(10):2614-23. (PMID: 19650040)
Thorax. 2014 Jul;69(7):638-47. (PMID: 24567297)
Sarcoma. 2011;2011:959248. (PMID: 21559216)
Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):15-22. (PMID: 30006019)
Int J Mol Sci. 2014 Mar 07;15(3):4142-57. (PMID: 24608926)
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8407-11. (PMID: 12815096)
Oncol Rep. 2015 Mar;33(3):1381-7. (PMID: 25572125)
Stem Cells. 2004;22(3):415-27. (PMID: 15153618)
EMBO J. 2012 Aug 29;31(17):3513-23. (PMID: 22773185)
Bone. 2006 Oct;39(4):706-15. (PMID: 16750945)
Am J Respir Cell Mol Biol. 2013 Oct;49(4):552-62. (PMID: 23656573)
Hum Cell. 2019 Jan;32(1):64-74. (PMID: 30506278)
Clin Orthop Relat Res. 2016 Mar;474(3):707-15. (PMID: 26018200)
Stem Cells Int. 2016;2016:1073140. (PMID: 26649044)
Front Pharmacol. 2016 Aug 03;7:231. (PMID: 27536241)
DNA Res. 2005;12(2):139-50. (PMID: 16303745)
Stem Cell Res Ther. 2010 Mar 15;1(1):2. (PMID: 20504283)
Oncogenesis. 2016 Mar 14;5:e210. (PMID: 26974205)
J Hum Genet. 2017 Jan;62(1):67-74. (PMID: 27383658)
Aging (Albany NY). 2019 Nov 7;11(21):9581-9596. (PMID: 31699956)
Cancer Cell. 2018 Oct 8;34(4):536-548. (PMID: 30146333)
Tumour Biol. 2017 May;39(5):1010428317701631. (PMID: 28468584)
J Clin Oncol. 2005 Jan 20;23(3):559-68. (PMID: 15659502)
Nat Cell Biol. 2019 Jan;21(1):9-17. (PMID: 30602770)
Int Orthop. 2015 Aug;39(8):1639-43. (PMID: 25795249)
Front Neurol. 2017 Feb 20;8:28. (PMID: 28265255)
J Cell Sci. 2010 Dec 15;123(Pt 24):4195-200. (PMID: 21123617)
Cytotherapy. 2015 Apr;17(4):369-81. (PMID: 25595330)
Mol Cancer. 2018 Oct 11;17(1):147. (PMID: 30309355)
Cancer Lett. 2011 Sep 1;308(1):91-9. (PMID: 21601983)
Mol Ther. 2015 Feb;23(2):235-43. (PMID: 25358253)
Oncogene. 2009 Jul 30;28(30):2745-55. (PMID: 19483720)
Trends Mol Med. 2012 Sep;18(9):534-43. (PMID: 22921864)
J Pathol. 2009 Nov;219(3):294-305. (PMID: 19718709)
Epigenetics. 2019 Apr;14(4):352-364. (PMID: 30907225)
Front Physiol. 2014 Jan 08;4:400. (PMID: 24409151)
Int J Biol Sci. 2016 Feb 05;12(4):389-96. (PMID: 27019624)
J Nanobiotechnology. 2018 Dec 20;16(1):103. (PMID: 30572882)
Chem Rev. 2018 Feb 28;118(4):1917-1950. (PMID: 29384376)
Injury. 2018 Dec;49(12):2326-2330. (PMID: 30526927)
Oncogene. 2010 Oct 21;29(42):5687-99. (PMID: 20676132)
Cell Death Dis. 2017 Jan 19;8(1):e2568. (PMID: 28102844)
Stem Cells. 2019 Jan;37(1):77-88. (PMID: 30281870)
Int J Cancer. 2021 Jan 1;148(1):128-139. (PMID: 32621791)
Stem Cells Transl Med. 2017 Feb;6(2):512-526. (PMID: 28191765)
Annu Rev Cell Dev Biol. 2014;30:255-89. (PMID: 25288114)
Mol Pharm. 2017 Nov 6;14(11):4079-4086. (PMID: 28977747)
Paediatr Drugs. 2008;10(5):315-27. (PMID: 18754698)
J Bone Joint Surg Am. 2006 Sep;88 Suppl 1 Pt 2:322-7. (PMID: 16951103)
Colloids Surf B Biointerfaces. 2015 Feb 1;126:381-6. (PMID: 25516267)
Stem Cell Res Ther. 2018 Jan 31;9(1):22. (PMID: 29386041)
Oncotarget. 2016 Jul 26;7(30):48296-48308. (PMID: 27340780)
Clin Cancer Res. 2017 Jul 15;23(14):3721-3733. (PMID: 28053020)
Transplantation. 2003 Mar 15;75(5):679-85. (PMID: 12640309)
Front Oncol. 2019 Dec 03;9:1342. (PMID: 31850225)
Clin Exp Med. 2017 Feb;17(1):59-69. (PMID: 26678086)
Ann Oncol. 2012 Oct;23 Suppl 7:vii100-9. (PMID: 22997441)
Clin Exp Immunol. 2014 Jun;176(3):473-84. (PMID: 24527865)
Front Immunol. 2018 Feb 19;9:262. (PMID: 29515580)
Bone. 2013 Jul;55(1):166-78. (PMID: 23486187)
فهرسة مساهمة: Keywords: 3TSR, Three type 1 repeats; 5 FC, 5-fluorocytosine; AD-MSCs, Adipose-derived MSCs; AQP1, Aquaporin-1; BMSC-derived exosomes, BMSC-Exos; BMSCs, Bone marrow mesenchymal stem cells; CAFs, Carcinoma-associated-fibroblasts; CRC, Colorectal cancer; CSF, Colony-stimulating factor; Cellular communication; Clinical application; DOX, Doxorubicin; DP-MSCs, Dental pulp-derived MSCs, hUC-MSCs, Human umbilical cord MSCs; ECM, Extracellular matrix; ESCs, embryonic stem cells; EVs, Extracellular vesicles; GBM, Glioblastoma; HCC, hepatocellular carcinoma; LINE-1, Long interspersing element 1; MCP-1, Monocyte chemoattractant protein-1; MSC-Exos, MSC-derived exosomes; MSC-MVs, MSC microvesicles; MSCs; MSCs, Mesenchymal stem cells; OPG, osteoprotegerin; OS, osteosarcoma; Osteosarcoma; PDGFRα, Platelet derived growth factor receptor α; PDGFRβ, Platelet derived growth factor receptor β; PDGFα, Platelet derived growth factor α; S TRAIL, Secretable variant of the TNF-related apoptosis-inducing ligand; SD-MSCs, stressed MSCs; SDF-1, Stromal cell-derived factor 1; TGF, Transforming growth factor; TME; TME, Tumor microenvironment; TNF, Tumor necrosis factor; TRA2B, Transformer 2β; VEGF, Vascular endothelial growth factor; hASCs, human adipose stem cells; iPSCs, induced pluripotent stem cells; yCD::UPRT, Yeast cytosine deaminase::uracil phosphoribosyl transferase
تواريخ الأحداث: Date Created: 20210714 Latest Revision: 20210715
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC8254115
DOI: 10.1016/j.jbo.2021.100372
PMID: 34258182
قاعدة البيانات: MEDLINE
الوصف
تدمد:2212-1366
DOI:10.1016/j.jbo.2021.100372